McKesson Ventures came onboard for the health data provider Evidation's series D round, helping it hike its overall funding to $106m five years after being co-founded by Stanford Health Care.
US-based health data provider Evidation Health completed a $45m series D round on Wednesday that included McKesson Ventures, the strategic investment arm of healthcare product distributor McKesson.
The round was led by venture capital firm B Capital Group and also featured Section 32, Revelation Partners, Rethink Impact and SV Health Investors. It increased the company’s funding to $106m since it was founded in 2012.
Evidation has created a software platform that passively collects data on everyday behaviour from…
